ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 171 filers reported holding ANI PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $359 | -99.8% | 6,661 | +34.3% | 0.02% | -74.2% |
| Q4 2018 | $223,000 | -85.5% | 4,961 | -81.8% | 0.06% | -81.4% |
| Q3 2018 | $1,543,000 | -23.1% | 27,295 | -9.1% | 0.33% | -20.1% |
| Q2 2018 | $2,006,000 | -0.8% | 30,034 | -13.5% | 0.42% | +6.4% |
| Q1 2018 | $2,022,000 | +2.8% | 34,726 | +13.8% | 0.39% | -15.5% |
| Q4 2017 | $1,966,000 | – | 30,505 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |